Zomedica (ZOMDF) director Johnny D. Powers buys 500,000 common shares

Rhea-AI Filing Summary

Zomedica Corp. director Johnny D. Powers reported buying a total of 500,000 shares of common stock in open-market transactions. He acquired 391,129 shares at an average price of $0.113 per share and 108,871 shares at $0.112 per share, increasing his direct ownership stake through personal share purchases.

Insider Trade Summary

Net Buyer: 500,000 shares ($56,391)

Net Buy 2 txns

Insider POWERS JOHNNY D

Role null

Bought 500,000 shs ($56K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, without par value	108,871	$0.112	$12K
Purchase	Common stock, without par value	391,129	$0.113	$44K

Holdings After Transaction: Common Stock, without par value — 3,533,871 shares (Direct, null); Common stock, without par value — 3,925,000 shares (Direct, null)

Footnotes (1)

Key Figures

Total shares purchased: 500,000 shares First trade size: 391,129 shares First trade price: $0.113/share +2 more

5 metrics

Total shares purchased 500,000 shares Aggregate insider open-market purchases reported

First trade size 391,129 shares Open-market purchase at $0.113 per share

First trade price $0.113/share Price for 391,129-share open-market purchase

Second trade size 108,871 shares Open-market purchase at $0.112 per share

Second trade price $0.112/share Price for 108,871-share open-market purchase

Key Terms

open-market purchase, Common stock, without par value, Form 4

3 terms

open-market purchase financial

"transaction_action: "open-market purchase" for both reported trades"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common stock, without par value financial

"security_title: "Common stock, without par value""

Form 4 regulatory

"INSIDER FILING DATA (Form 4) for Zomedica Corp."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POWERS JOHNNY D

(Last) (First) (Middle)

1101 TECHNOLOGY DRIVE

STE 100

(Street)

ANN ARBOR MICHIGAN 48108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zomedica Corp. [ ZOMDF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, without par value	05/08/2026		P		108,871	A	$0.112	3,533,871	D
Common stock, without par value	05/11/2026		P		391,129	A	$0.113	3,925,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/Johnny D. Powers	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Zomedica (ZOMDF) disclose in this Form 4?

Zomedica disclosed that director Johnny D. Powers bought 500,000 common shares in open-market transactions. The filing shows two purchases, both at prices slightly above ten cents per share, increasing his directly held stake in the company’s stock.

How many Zomedica (ZOMDF) shares did Johnny D. Powers purchase?

Johnny D. Powers purchased a total of 500,000 Zomedica common shares. The Form 4 breaks this into 391,129 shares and 108,871 shares, both recorded as open-market purchases that added to his direct ownership position in the company.

At what prices did the Zomedica (ZOMDF) director buy shares?

The director’s open-market purchases were made at prices around eleven cents per share. He bought 391,129 shares at $0.113 each and 108,871 shares at $0.112 each, according to the Form 4 transaction detail.

Is the Zomedica (ZOMDF) insider transaction a buy or a sell?

The Form 4 shows only insider buying activity. Johnny D. Powers executed two open-market purchases classified with code “P,” which represents a purchase, and the transaction summary reports 500,000 net buy shares with no corresponding insider sales.

What type of security did the Zomedica (ZOMDF) director acquire?

The insider acquired Zomedica common stock, without par value. Both reported transactions involve non-derivative common shares purchased directly in the open market, rather than options, warrants, or other derivative securities, according to the Form 4 disclosure.